Committed under
Acepre, LLC
$897,310 committed in all years on record · 0.0% of the program
- Full records
- Acepre, LLC → everything they’re paid, across every program and agencyAllergy and Infectious Diseases Research → the whole program, every recipientDepartment of Health and Human Services → everything they pay out
By fiscal year
Allergy and Infectious Diseases Research dollars committed to Acepre, LLC, per fiscal year.
Awards
The largest awards to Acepre, LLC under this program.
Targeting Macrophage Maladaptation for Bacterial Sepsis Treatment - Summary. Sepsis Results in Massive Loss of Life and Places a Significant…
May 24, 2024$597,310
Use Novel Natural Compound Sparstolonin B to Treat Bacterial Sepsis - Summary: According to the Most Recent CDC Report, the Incidence of Sep…
How to read these numbers
- Just these two
Every figure is money committed to this recipient under this one program — nothing they get anywhere else, from this program or any other.
- Totals by action year
The aggregates reflect the fiscal year picked at the top, counted in the year each action happened.
- “Active in FY X”
The award list shows every award between the two with an action that year, at its full lifetime value — so a single award's amount can top that year's committed total.
- From FY2018 on
Pairing pages start at fiscal year 2018, the first year of complete assistance reporting.
- The colored bars
Every bar on this page splits by how the money moves:
Direct paymentsGrants
